Clinical Trial Update: A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This update describes a Phase 2 study of the combination of atezolizumab and bevacizumab for unresectable hepatocellular carcinoma. The trial is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Howard S Hochster | Conditions: Unresectable Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING